Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase 1/2 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 145 Breast Neoplasms 113 Prostatic Neoplasms 58 Multiple Myeloma 57 Neoplasms 54 Lung Neoplasms 46 Neoplasm Metastasis 42 Ovarian Neoplasms 36 Parkinson Disease 4, Autosomal Dominant Lewy Body 34 Leukemia, Lymphocytic, Chronic, B-Cell 33 Colorectal Neoplasms 32 Carcinoma, Renal Cell 26 Recurrence 25 Leukemia, Myeloid, Acute 25 Urinary Bladder Neoplasms 23 Myasthenia Gravis 23 Carcinoma, Hepatocellular 23 Triple Negative Breast Neoplasms 21 Lymphoma, Large B-Cell, Diffuse 21 Squamous Cell Carcinoma of Head and Neck 20 Small Cell Lung Carcinoma 20 Lymphoma, Follicular 18 Fallopian Tube Neoplasms 18 Endometrial Neoplasms 18 Stomach Neoplasms 17 Nasopharyngeal Carcinoma 17 Melanoma 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Pancreatic Neoplasms 15 Non-Muscle Invasive Bladder Neoplasms 15

Interventions

tegafur-gimeracil-oteracil 1 Radiation 1 Oxaliplatin 1 Magnetic Resonance Imaging 1 Leucovorin 1 Irinotecan 1 Induction Chemotherapy 1 Folfox protocol 1 Fluorouracil 1 FOLFOXIRI protocol 1 Endoscopy 1 Colonoscopy 1 Chemoradiotherapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pathologic Complete Response × 90 days × Clear all

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡